BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

764 related articles for article (PubMed ID: 16084554)

  • 21. A conventional, inactivated oil emulsion vaccine suppresses shedding and prevents viral meat colonisation in commercial (Pekin) ducks challenged with HPAI H5N1.
    Beato MS; Toffan A; De Nardi R; Cristalli A; Terregino C; Cattoli G; Capua I
    Vaccine; 2007 May; 25(20):4064-72. PubMed ID: 17420074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long lasting immunity in chickens induced by a single shot of influenza vaccine prepared from inactivated non-pathogenic H5N1 virus particles against challenge with a highly pathogenic avian influenza virus.
    Sasaki T; Kokumai N; Ohgitani T; Sakamoto R; Takikawa N; Lin Z; Okamatsu M; Sakoda Y; Kida H
    Vaccine; 2009 Aug; 27(38):5174-7. PubMed ID: 19596414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of vaccines in chickens against highly pathogenic Hong Kong H5N1 avian influenza.
    Swayne DE; Beck JR; Perdue ML; Beard CW
    Avian Dis; 2001; 45(2):355-65. PubMed ID: 11417815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a recombinant fowlpox virus vector-based vaccine of H5N1 subtype avian influenza.
    Qiao C; Yu K; Jiang Y; Li C; Tian G; Wang X; Chen H
    Dev Biol (Basel); 2006; 124():127-32. PubMed ID: 16447503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques.
    Itoh Y; Ozaki H; Tsuchiya H; Okamoto K; Torii R; Sakoda Y; Kawaoka Y; Ogasawara K; Kida H
    Vaccine; 2008 Jan; 26(4):562-72. PubMed ID: 18164788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prime-boost vaccination with recombinant H5-fowlpox and Newcastle disease virus vectors affords lasting protection in SPF Muscovy ducks against highly pathogenic H5N1 influenza virus.
    Niqueux E; Guionie O; Amelot M; Jestin V
    Vaccine; 2013 Aug; 31(38):4121-8. PubMed ID: 23845804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of commercial vaccines in protecting chickens and ducks against H5N1 highly pathogenic avian influenza viruses from Vietnam.
    Pfeiffer J; Suarez DL; Sarmento L; To TL; Nguyen T; Pantin-Jackwood MJ
    Avian Dis; 2010 Mar; 54(1 Suppl):262-71. PubMed ID: 20521643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
    Kapczynski DR; Esaki M; Dorsey KM; Jiang H; Jackwood M; Moraes M; Gardin Y
    Vaccine; 2015 Feb; 33(9):1197-205. PubMed ID: 25613723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reverse genetics based rgH5N2 vaccine provides protection against high dose challenge of H5N1 avian influenza virus in chicken.
    Bhatia S; Khandia R; Sood R; Bhat S; Siddiqui A; Jahagirdhar G; Mishra S; Mishra A; Pateriya AK; Kulkarni DD
    Microb Pathog; 2016 Aug; 97():172-7. PubMed ID: 27296706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An inactivated H5N2 vaccine reduces transmission of highly pathogenic H5N1 avian influenza virus among native chickens.
    Poetri ON; Bouma A; Murtini S; Claassen I; Koch G; Soejoedono RD; Stegeman JA; van Boven M
    Vaccine; 2009 May; 27(21):2864-9. PubMed ID: 19428896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A vaccine prepared from a non-pathogenic H5N1 influenza virus strain from the influenza virus library conferred protective immunity to chickens against the challenge with antigenically drifted highly pathogenic avian influenza virus.
    Samad RA; Nomura N; Tsuda Y; Manzoor R; Kajihara M; Tomabechi D; Sasaki T; Kokumai N; Ohgitani T; Okamatsu M; Takada A; Sakoda Y; Kida H
    Jpn J Vet Res; 2011 Feb; 59(1):23-9. PubMed ID: 21476487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective efficacy of the H5 inactivated vaccine against different highly pathogenic H5N1 avian influenza viruses isolated in China and Vietnam.
    Tian G; Zeng X; Li Y; Shi J; Chen H
    Avian Dis; 2010 Mar; 54(1 Suppl):287-9. PubMed ID: 20521646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction of a recombinant duck enteritis virus (DEV) expressing hemagglutinin of H5N1 avian influenza virus based on an infectious clone of DEV vaccine strain and evaluation of its efficacy in ducks and chickens.
    Wang J; Ge A; Xu M; Wang Z; Qiao Y; Gu Y; Liu C; Liu Y; Hou J
    Virol J; 2015 Aug; 12():126. PubMed ID: 26263920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A vaccine prepared from a non-pathogenic H7N7 virus isolated from natural reservoir conferred protective immunity against the challenge with lethal dose of highly pathogenic avian influenza virus in chickens.
    Sakabe S; Sakoda Y; Haraguchi Y; Isoda N; Soda K; Takakuwa H; Saijo K; Sawata A; Kume K; Hagiwara J; Tuchiya K; Lin Z; Sakamoto R; Imamura T; Sasaki T; Kokumai N; Kawaoka Y; Kida H
    Vaccine; 2008 Apr; 26(17):2127-34. PubMed ID: 18346824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple dose vaccination with heterologous H5N2 vaccine: immune response and protection against variant clade 2.2.1 highly pathogenic avian influenza H5N1 in broiler breeder chickens.
    Abdelwhab EM; Grund C; Aly MM; Beer M; Harder TC; Hafez HM
    Vaccine; 2011 Aug; 29(37):6219-25. PubMed ID: 21745517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pekin and Muscovy ducks respond differently to vaccination with a H5N1 highly pathogenic avian influenza (HPAI) commercial inactivated vaccine.
    Cagle C; To TL; Nguyen T; Wasilenko J; Adams SC; Cardona CJ; Spackman E; Suarez DL; Pantin-Jackwood MJ
    Vaccine; 2011 Sep; 29(38):6549-57. PubMed ID: 21771626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and application of avian influenza vaccines in China.
    Chen H; Bu Z
    Curr Top Microbiol Immunol; 2009; 333():153-62. PubMed ID: 19768404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and use of fowlpox vectored vaccines for avian influenza.
    Bublot M; Pritchard N; Swayne DE; Selleck P; Karaca K; Suarez DL; Audonnet JC; Mickle TR
    Ann N Y Acad Sci; 2006 Oct; 1081():193-201. PubMed ID: 17135511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.